EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots

Europe's medicines regulator on Wednesday said it still believes the benefits of Johnson & Johnson's Covid-19 vaccine outweigh the risks of side effects.

from Health and Science https://ift.tt/32dYgd4
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH